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Ginseng, a perennial plant belonging to the genus Panax of the Araliaceae family, is well known for its
medicinal properties that help alleviate pathological symptoms, promote health, and prevent potential
diseases. Among the active ingredients of ginseng are saponins, most of which are glycosides of tri-
terpenoid aglycones. So far, numerous saponins have been reported as components of Panax ginseng, also
known as Korean ginseng. Herein, we summarize available information about 112 saponins related to
P. ginseng; >80 of them are isolated from raw or processed ginseng, and the others are acid/base hy-
drolysates, semisynthetic saponins, or metabolites.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ginseng has been one of the most important components in a
number of East Asian herbal remedies. In fact, the term ginseng,
without any modiﬁer, refers particularly to the species Panax
ginseng Meyer or sometimes even more speciﬁcally to the root of
the plant species. As the name ginseng carries authority and
veneration in East Asian medicine, other plants that have some
properties in common with P. ginseng have been allegedly called
“ginseng”. Eventually, ginseng has become a blanket term that
encompasses >10 species of perennial plants belonging to the
genus Panax of the family Araliaceae [1,2]. Currently, 14 plants,
including 12 species and two infraspeciﬁc taxa, have been recog-
nized as members of the genus Panax, as shown in Table 1 [3]. Some
of the Panax plants have common names, which stem from their
countries of origin: P. ginseng, Panax japonicus, Panax notoginseng,
Panax quinquefolius, and Panax vietnamensis are also called Korean
ginseng, Japanese ginseng, Chinese ginseng, American ginseng, and
Vietnamese ginseng, respectively. Of the Panax plants, Korean
ginseng, Chinese ginseng, and American ginseng have been
commercially cultivated; Vietnamese ginseng has recently beenl National University, 1 Gwanak-ro
ht  2015, The Korean Society of G
c-nd/4.0/).introduced for agriculture. Most ginseng species are native to Asia,
especially East Asia. Thus, the use of equivocal names, such as Asian
ginseng that often refers to P. ginseng, is discouraged.
While the variety of species renders some pharmacological ef-
fects speciﬁc to certain species, ginseng, in general, displays
restorative, tonic, and revitalizing properties [4]. Thus far, >6,000
articles regarding the traditional uses, chemical constituents, and
biological and pharmacological effects of ginseng have been pub-
lished since Petkov [5] reported the pharmacological properties of
P. ginseng extracts in the 1950s. Such pharmacological activities of
ginseng have been found to be mainly attributed to ginseng sapo-
nins, also known as ginsenosides [6e11].
Since the ﬁrst isolation of six ginsenosides from P. ginseng in the
1960s [12], plenty of ginsenosides have been isolated and identiﬁed
from the species. In this review, we recapitulate the chemical
structures, molecular masses, and monoisotopic masses of sapo-
nins from various parts of P. ginseng, including roots, ﬂower buds,
fruits, and leaves. In addition, we furnish available information
about artifactual saponins formed during physicochemical and/or
biological treatment and compounds synthesized from saponins
isolated from P. ginseng., Gwanak-gu, Seoul 151-742, Korea.
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
Table 1
Scientiﬁc and common names of panax plants
Scientiﬁc name Rank Common name
Panax bipinnatiﬁdus Seem Species
Panax bipinnatiﬁdus var. angustifolius Infraspeciﬁc
taxon
Panax bipinnatiﬁdus var. bipinnatiﬁdus Infraspeciﬁc
taxon
Panax ginseng C. A. Mey. Species Korean ginseng,
Ginseng
Panax japonicus (T. Nees) C. A. Mey. Species Japanese ginseng
Panax notoginseng (Burkill) F. H. Chen Species Chinese ginseng,
sanchi
Panax pseudoginseng Wall. Species
Panax quinquefolius L. Species American ginseng
Panax sokpayensis Shiva K. Sharma & Pandit Species
Panax stipuleanatus H. T. Tsai & K. M. Feng Species
Panax trifolius L. Species
Panax vietnamensis Ha & Grushv. Species Vietnamese ginseng
Panax wangianus S. C. Sun Species
Panax zingiberensis C. Y. Wu & Feng Species
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structures
Most ginseng saponins are believed to be biosynthesized from
2,3-oxidosqualene, which is also the precursor of b-sitosterol, a
steroid commonly found in plants [13]. It has been suggested that
the action of three different enzymes on 2,3-oxidosqualene leads to
the formation of cycloartenol, dammarenediol-II, and b-amyrin, the
latter two of which are eventually biotransformed into ginseng
saponins. Fig. 1 shows the proposed biosynthetic pathway of
ginseng saponins and b-sitosterol. Dammarenediol-II is the pre-
cursor of dammarane-type saponins, including ginsenosides Rb1,
Rb2, Re, and Rg1, which account for a signiﬁcant portion of sapo-
nins found in ginseng species. Dammarane-type saponins are
further classiﬁed into various groups. By contrast, oleanane-type
saponins are biosynthesized from b-amyrin. In P. ginseng, howev-
er, oleanane-type saponins other than ginsenoside Ro are rare and
often practically undetectable.
Table 2 [14e67] displays the molecular formulas, molecular
masses, monoisotopic masses, and parts of ginseng saponins, iso-
lated from or related to P. ginseng, that are used. We categorize theFig. 1. Biosynthetic pathways of ginseng saponins. 2,3-Oxidosqualene may be cyclized int
precursor of dammarane-type saponins and oleanane-type saponins, respectively.ginseng saponins based upon the position of hydroxyl group(s)
and/or double bond(s) of their genins.2.1. Protopanaxadiol, protopanaxatriol, and their glycosides
As shown in Fig. 1, dammarenediol-II is hydroxylated to proto-
panaxadiol (PPD), 3b,12b,20-trihydroxydammar-24-ene. Ulti-
mately, a number of saponins are biosynthesized by O-
glycosylation of PPD that involves the attachment of saccharide(s)
to C-3 and/or C-20. Typical PPD-type saponins include ginsenosides
Rb1, Rb2, Rc, and Rd, which are found in the roots [19,20], ﬂower
buds [21], and leaves [21] of P. ginseng.
PPD may further be hydroxylated to protopanaxatriol (PPT),
3b,6a,12b,20-tetrahydroxydammar-24-ene. A variety of saponins
are biosynthesized by O-glycosylation of PPT that involves the
attachment of saccharide(s) to C-6 and/or C-20. Typically, the hy-
droxyl group at C-3 remains free in PPT-type ginsenosides. The two
most abundant PPT-type saponins in P. ginseng are ginsenosides Re
and Rg1.
Fig. 2A illustrates the structures of PPD- and PPT-type saponins.
While most naturally occurring ginsenosides are of the (S)-
conﬁguration at C-20, some artifactual ginsenosides exist in two
epimeric forms at the carbon.2.2. Peroxidation products of PPD- and PPT-type saponins
Some saponins isolated from the ﬂower buds of P. ginseng have
an aglycone that is believed to be produced via the peroxidation of
PPD or PPT [68]. In most cases, the peroxidation occurs at or around
the double bond between C-24 and C-25, and eventually leads to
various structures. Fig. 2B, C show the structures of ginsenosides
whose genin appears to be produced via the peroxidation of PPD or
PPT. Fig. 2B-(a) shows the structures of some saponins that have a
hydroperoxyl group at C-24 and a double bond between C-25 and
C-26. Fig. 2B-(b) contains the genin structure that has a hydroxyl
group at C-24, which would be reduced from the hydroperoxyl
group shown in Fig. 2B-(a). In addition, Fig. 2B-(c) shows the
structure of ﬂoralginsenoside Ta, a glycoside of 3b,6a,12b,20-
tetrahydroxydammar-24-one-25-ene, which may be considered
to be formed by the dehydration of ﬂoralginsenoside Ka, whose
structure is illustrated in Fig. 2B-(a).o three different compounds, two of which are dammarenediol-II and b-amyrin, the
Table 2
Useful information about saponins isolated from p. ginseng, synthetic saponins, and saponin metabolites
No. Saponin Formula Backbone (Fig. 2) Molecular mass (u) 1) Monoisotopic mass (u) 1) Plant part (process) Refs
Saponins from Panax ginseng
1 Protopanaxadiol C30H52O3 A 460.73 460.3916 (Hydrolysis) [14,15]
2 Ginsenoside F2 C42H72O13 A 785.01 784.4973 Leaves [16]
3 Ginsenoside Ra1 C58H98O26 A 1,211.38 1,210.6346 Roots [17]
4 Ginsenoside Ra2 C58H98O26 A 1,211.38 1,210.6346 Roots [17]
5 Ginsenoside Ra3 C59H100O27 A 1,241.41 1,240.6452 Roots [18]
6 Ginsenoside Rb1 C54H92O23 A 1,109.29 1,108.6029 Roots [19e22]
7 Ginsenoside Rb2 C53H90O22 A 1,079.27 1,078.5924 Roots [19e21]
8 Ginsenoside Rb3 C53H90O22 A 1,079.27 1,078.5924 Roots [23]
9 Ginsenoside Rc C53H90O22 A 1,079.27 1,078.5924 Roots [19e21]
10 Ginsenoside Rd C48H82O18 A 947.15 946.5501 Roots [19e21,24]
11 Ginsenoside Rg3 C42H72O13 A 785.01 784.4973 Steamed roots [20,25]
12 Ginsenoside Rh2 C36H62O8 A 622.87 622.4445 Steamed roots [25]
13 Ginsenoside Rs1 C55H92O23 A 1,121.31 1,120.6029 Roots [20]
14 Ginsenoside Rs2 C55H92O23 A 1,121.31 1,120.6029 Roots [20]
15 Ginsenoside Rs3 C44H74O14 A 827.05 826.5079 Steamed roots [26]
16 Malonylginsenoside Ra3 C62H102O30 A 1,327.46 1,326.6456 Roots [27]
17 Malonylginsenoside Rb1 C57H94O26 A 1,195.34 1,194.6033 Roots [28]
18 Malonylginsenoside Rb2 C56H92O25 A 1,165.31 1,164.5928 Roots [28]
19 Malonylginsenoside Rc C56H92O25 A 1,165.31 1,164.5928 Roots [28]
20 Malonylginsenoside Rd C51H84O21 A 1,033.20 1,032.5505 Roots [28]
21 Malonylnotoginsenoside R4 C62H102O30 A 1,327.46 1,326.6456 Roots [29]
22 Protopanaxatriol C30H52O4 A 476.73 476.3866 (Hydrolysis) [30]
23 Floralginsenoside M C53H90O22 A 1,079.27 1,078.5924 Flower buds [31]
24 Floralginsenoside N C53H90O22 A 1,079.27 1,078.5924 Flower buds [31]
25 Floralginsenoside P C53H90O23 A 1,095.27 1,094.5873 Flower buds [31]
26 Ginsenoside F1 C36H62O9 A 638.87 638.4394 Leaves [16]
27 Ginsenoside F3 C41H70O13 A 770.99 770.4816 Leaves [16]
28 Ginsenoside Re C48H82O18 A 947.15 946.5501 Roots [20,21,24,32]
29 Ginsenoside Rf C42H72O14 A 801.01 800.4922 Roots [20,32]
30 Ginsenoside Rg1 C42H72O14 A 801.01 800.4922 Roots [20,21,33]
31 Ginsenoside Rg2 C42H72O13 A 785.01 784.4973 Roots [25,32,34,35]
32 Ginsenoside Rh1 C36H62O9 A 638.87 638.4394 Steamed roots [21,25,34]
33 20-Glucoginsenoside Rf C48H82O19 A 963.15 962.5450 Roots [23]
34 Floralginsenoside H C50H84O21 B-(a) 1,021.19 1,020.5505 Flower buds [36]
35 Floralginsenoside Tc C53H90O24 B-(a) 1,111.27 1,110.5822 Flower buds [37]
36 Floralginsenoside Td C53H90O24 B-(a) 1,111.27 1,110.5822 Flower buds [37]
37 Ginsenoside I C48H82O20 B-(a) 979.15 978.5400 Flower buds [38]
38 Ginsenoside II C48H82O20 B-(a) 979.15 978.5400 Flower buds [38]
39 Floralginsenoside A C42H72O16 B-(a) 833.01 832.4820 Flower buds [39]
40 Floralginsenoside C C41H70O15 B-(a) 802.99 802.4715 Flower buds [39]
41 Floralginsenoside J C48H82O20 B-(a) 979.15 978.5400 Flower buds [36]
42 Floralginsenoside Ka C36H62O11 B-(a) 670.87 670.4292 Flower buds [40]
43 Ginsenoside SL1 C36H62O11 B-(a) 670.87 670.4292 Steamed leaves [41]
44 Ginsenoside Rg7 C36H60O9 B-(b) 636.86 636.4237 Leaves [42]
45 Floralginsenoside La C48H82O19 B-(b) 963.15 962.5450 Flower buds [36]
46 Floralginsenoside Lb C48H82O19 B-(b) 963.15 962.5450 Flower buds [36]
47 Floralginsenoside Ta C36H60O10 B-(c) 652.86 652.4187 Flower buds [37]
48 Floralginsenoside E C42H72O15 C-(a) 817.01 816.4871 Flower buds [39]
49 Floralginsenoside F C42H72O15 C-(a) 817.01 816.4871 Flower buds [39]
50 Floralginsenoside G C50H84O21 C-(a) 1,021.19 1,020.5505 Flower buds [36]
51 Floralginsenoside K C48H82O21 C-(a) 995.15 994.5349 Flower buds [36]
52 Floralginsenoside O C53H90O22 C-(a) 1,079.27 1,078.5924 Flower buds [31]
53 Floralginsenoside B C42H72O16 C-(a) 833.01 832.4820 Flower buds [39]
54 Floralginsenoside D C41H70O15 C-(a) 802.99 802.4715 Flower buds [39]
55 Floralginsenoside I C48H82O20 C-(a) 979.15 978.5400 Flower buds [36]
56 Ginsenoside Rh6 C36H62O11 C-(a) 670.87 670.4292 Leaves [42]
57 Ginsenoside ST2 C36H62O10 C-(b) 654.87 654.4343 Steamed leaves [43]
58 Ginsenoside Ki C36H62O10 C-(c) 654.87 654.4343 Leaves [44]
59 Ginsenoside Km C36H62O10 C-(c) 654.87 654.4343 Leaves [44]
60 Floralginsenoside Kb C45H76O19 D-(a) 921.07 920.4981 Flower buds [40]
61 Floralginsenoside Kc C45H76O20 D-(a) 937.07 936.4930 Flower buds [40]
62 Floralginsenoside Tb C35H62O11 D-(b) 658.86 658.4292 Flower buds [37]
63 25-Hydroxyprotopanaxadiol C30H54O4 E 478.75 478.4022 Fruits [45]
64 25-Hydroxyprotopanaxatriol C30H54O5 E 494.75 494.3971 Fruits [45]
65 Dehydroprotopanaxadiol I C30H50O2 F-(a) 442.72 442.3811 Steamed roots [46]
66 Ginsenoside Rg5 C42H70O12 F-(a) 767.00 766.4867 Steamed roots [47,48]
67 Ginsenoside Rh3 C36H60O7 F-(a) 604.86 604.4339 Steamed roots [47,49]
68 Ginsenoside Rs4 C44H72O13 F-(a) 809.03 808.4973 Steamed roots [46]
69 Dehydroprotopanaxatriol I C30H50O3 F-(a) 458.72 458.3760 Steamed roots [46]
70 Ginsenoside F4 C42H70O12 F-(a) 767.00 766.4867 Leaves [50]
71 Ginsenoside Rh4 C36H60O8 F-(a) 620.86 620.4288 Steamed roots [47,51]
72 Ginsenoside Rs6 C38H62O9 F-(a) 662.89 662.4394 Steamed roots [46]
(continued on next page)
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Table 2 (continued )
No. Saponin Formula Backbone (Fig. 2) Molecular mass (u) 1) Monoisotopic mass (u) 1) Plant part (process) Refs
73 Ginsenoside Rz1 C42H70O12 F-(b) 767.00 766.4867 Steamed roots [52]
74 Dehydroprotopanaxadiol II C30H50O2 F-(c) 442.72 442.3811 Steamed roots [46]
75 Ginsenoside Rk1 C42H70O12 F-(c) 767.00 766.4867 Steamed roots [47]
76 Ginsenoside Rk2 C36H60O7 F-(c) 604.86 604.4339 Steamed roots [47]
77 Ginsenoside Rs5 C44H72O13 F-(c) 809.03 808.4973 Steamed roots [46]
78 Dehydroprotopanaxatriol II C30H50O3 F-(c) 458.72 458.3760 Steamed roots [46]
79 Ginsenoside Rg6 C42H70O12 F-(c) 767.00 766.4867 Steamed roots [53]
80 Ginsenoside Rk3 C36H60O8 F-(c) 620.86 620.4288 Steamed roots [47]
81 Ginsenoside Rs7 C38H62O9 F-(c) 662.89 662.4394 Steamed roots [46]
82 Panaxadiol C30H52O3 G-(a) 460.73 460.3916 (Hydrolysis) [54,55]
83 Panaxatriol C30H52O4 G-(a) 476.73 476.3866 (Hydrolysis) [30]
84 Ginsenoside Rh9 C36H60O9 G-(b) 636.86 636.4237 Leaves [42]
85 12,23-Epoxyginsenoside Rg1 C42H70O14 G-(b) 799.00 798.4766 Leaves [56]
86 Panaxadione C30H48O5 G-(c) 488.70 488.3502 Seeds [57]
87 Ginsenoside Rh5 C36H60O9 H-(a) 636.86 636.4237 Steamed roots [42]
88 Ginsenoside Rh7 C36H60O9 H-(b) 636.86 636.4237 Leaves [42]
89 Ginsenoside Rh8 C36H60O9 H-(c) 636.86 636.4237 Leaves [42]
90 Ginsenoside Ro C48H76O19 H-(d) 957.11 656.4981 Roots [19,22,58]
91 Ginsenoside SL2 C42H70O14 I-(a) 799.00 798.4766 Steamed leaves [41]
92 Ginsenoside ST1 C36H60O10 I-(a) 652.86 652.4187 Steamed leaves [43]
93 Ginsenoside SL3 C42H70O14 I-(b) 799.00 798.4766 Steamed leaves [41]
94 Hexanordammaran C24H40O4 I-(c) 392.57 392.2927 Leaves [59]
95 Isoprotopanaxadiol C30H52O3 I-(d) 460.73 460.3916 (Hydrolysis) [60]
Synthetic saponins
96 Ginsenoside DM1 C48H84O9 J-(a) 805.18 804.6115 (Synthesis) [61]
97 Ginsenoside PM1 C52H92O9 J-(a) 861.28 860.6741 (Synthesis) [61]
98 Ginsenoside SM1 C54H96O9 J-(a) 889.33 888.7054 (Synthesis) [61]
99 C-X1 C53H90O23 J-(a) 1,095.27 1,094.5873 (Synthesis) [62]
100 C-Y1 C53H90O23 J-(a) 1,095.27 1,094.5873 (Synthesis) [62]
101 C-Y2 C42H72O14 J-(a) 801.01 800.4922 (Synthesis) [62]
102 Ginsenoside ORh1 C44H76O10 J-(a) 765.07 764.5439 (Synthesis) [63]
103 Ocotillol derivative 3a C36H62O10 J-(b) 654.87 654.4343 (Synthesis) [64]
104 Ocotillol derivative 3b C36H62O10 J-(b) 654.87 654.4343 (Synthesis) [64]
105 Ginsenoside Rp1 C42H74O12 J-(c) 771.03 770.5180 (Synthesis) [65]
Saponin metabolites
106 M1 (Compound K) C36H62O8 K 622.87 622.4445 (Metabolization) [66]
107 M2 (Compound Y) C41H70O12 K 754.99 754.4867 (Metabolization) [66]
108 M3 (Ginsenoside Mc) C41H70O12 K 754.99 754.4867 (Metabolization) [66]
109 M6 C47H80O17 K 917.13 916.5396 (Metabolization) [66]
110 M7 (Ginsenoside Mb) C47H80O17 K 917.13 916.5396 (Metabolization) [66]
111 M9 (Gp-LXXV) C48H82O18 K 947.15 946.5501 (Metabolization) [66]
112 M13 (Gp-XVII) C42H72O13 K 785.01 784.4973 (Metabolization) [66]
1) The calculations are based upon the latest atomic mass data from the International Union of Pure and Applied Chemistry (IUPAC) [67].
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saponins whose genin has a hydroperoxyl group and a hydroxyl
group, respectively, at C-25 and a double bond between C-23 and C-
24. While geometric isomerism is possible in compounds with a
double bond between C-23 and C-24, most of those reported are
the (E)-form isomers rather than the (Z)-form. In addition, Fig. 2C-
(c) illustrates the structures of ginsenosides whose genin has a
hydroxyl group either at C-26 or at C-27, which would be reduced
from the hydroperoxyl group formed around the double bond be-
tween C-24 and C-25.2.3. Cleavage products of PPD- and PPT-type saponins
The oxidative cleavage of the double bond of some saponins
yields an aldehyde with three fewer carbon atoms, that is,
3b,12b,20-trihydroxy-25,26,27-trinordammar-24-al, and its de-
rivatives, which are found mainly in the ﬂower buds of ginseng.
Fig. 2D-(a) shows the structures of ginsenosides whose genin is
considered to be formed by the oxidative cleavage of the double
bond of PPD or 23-hydroxyprotopanaxadiol. Fig. 2D-(b) shows the
structure of ﬂoralginsenoside Tb, whose genin is an acetal of
3b,6a,12b,20-tetrahydroxy-25,26,27-trinordammar-24-al, which
appears to be formed from PPT.2.4. Hydration and dehydration products of PPD- and PPT-type
saponins
The hydration of the double bond of PPD or PPT yields a dam-
marane derivative with a hydroxyl group at C-25 and no double
bond. Fig. 2E illustrates the structures of the saponins 25-
hydroxyprotopanaxadiol and 25-hydroxyprotopanaxatriol.
Most PPD- and PPT-type ginsenosides tend to be deglycosylated
and dehydrated at C-20 when steamed or heat processed. The
resultant double bond is formed either between C-20 and C-21 or
between C-20 and C-22. In the latter case, the (E)/(Z) geometric
isomerism exists. Fig. 3 illustrates the probable pathways of the
formation of artifactual saponins owing to heating. Fig. 2F shows
the structures of saponins that are considered to be the dehydration
products of the PPD- and PPT-type saponins shown in Fig. 2A.
2.5. Saponins with an epoxy group
The acid hydrolysis of a PPD-type and a PPT-type saponin leads
to the formation of a six-membered ring containing oxygen,
yielding panaxadiol, 3b,12b-dihydroxy-20,25-epoxydammarane,
and panaxatriol, 3b,6a,12b-trihydroxy-20,25-epoxydammarane,
respectively. Fig. 2G-(a) shows the structures of panaxadiol and
panaxatriol. Moreover, some saponins are derivatives of 3b,6a,20-
Fig. 2. Structures of ginseng saponins. A. Structures of ginseng saponins whose genin is 3b,12b,20-trihydroxydammar-24-ene (protopanaxadiol)/3b,6a,12b,20-tetrahydrox-
ydammar-24-ene (protopanaxatriol); B. Structures of ginseng saponins whose genin is (a) 3b,12b,20-trihydroxy-24-hydroperoxydammar-25-ene/3b,6a,12b,20-tetrahydroxy-24-
hydroperoxydammar-25-ene; (b) 3b,12b,20,24-tetrahydroxydammar-25-ene/3b,6a,12b,20,24-pentahydroxydammar-25-ene; (c) 3b,6a,12b,20-tetrahydroxydammar-24-one-25-
ene; C. Structures of ginseng saponins whose genin is (a) (E)-3b,12b,20-trihydroxy-25-hydroperoxydammar-23-ene/(E)-3b,6a,12b,20-tetrahydroxy-25-hydroperoxydammar-23-
ene; (b) (E)-3b,6a,12b,20,25-pentahydroxydammar-23-ene; (c) 3b,6a,12b,26-tetrahydroxydammar-24-ene/3b,6a,12b,27-tetrahydroxydammar-24-ene; D. Structures of ginseng sa-
ponins whose genin is (a) 3b,12b,20-trihydroxy-25,26,27-trinordammar-24-al/3b,12b,20,23-tetrahydroxy-25,26,27-trinordammar-24-al; (b) 3b,6a,12b,20-tetrahydroxy-24,24-
dimethoxy-25,26,27-trinordammarane; E. Structures of ginseng saponins whose genin is 3b,12b,20,25-tetrahydroxydammarane/3b,6a,12b,20,25-pentahydroxydammarane; F.
Structures of ginseng saponins whose genin is (a) (E)-3b,12b-dihydroxydammar-20(22),24-diene/(E)-3b,6a,12b-trihydroxydammar-20(22),24-diene; (b) (Z)-3b,12b-dihydrox-
ydammar-20(22),24-diene; (c) 3b,12b-dihydroxydammar-20(21),24-diene/3b,6a,12b-trihydroxydammar-20(21),24-diene; G. Structures of ginseng saponins whose genin is (a)
3b,12b-dihydroxy-20,25-epoxydammarane (panaxadiol)/3b,6a,12b-trihydroxy-20,25-epoxydammarane (panaxatriol); (b) 3b,6a,20-trihydroxy-12,23-epoxydammar-24-ene; (3)
6a,25-dihydroxy-20,24-epoxydammar-3,12-dione; H. Structure of a ginseng saponin whose genin is (a) 3b,6a,12b,24-tetrahydroxydammar-20(22),25-diene; (b) 3b,7b,12b,20-tet-
rahydroxydammar-5,24-diene; (c) 3b,6a,20-trihydroxydammar-12-one-24-ene; (d) oleanolic acid; I. Structures of ginseng saponins whose genin is (a) 3b,6a,12b-trihydroxy-24-
hydroperoxydammar-20(22),25-diene; (b) 3b,6a,12b-trihydroxy-23-hydroperoxydammar-20(21),24-diene; (c) 3b,6a,12b-trihydroxy-22,23,24,25,26,27-hexanordammar-20-one;
(d) (E)-3b,12b,25-trihydroxydammar-20(22)-ene; J. Structures of synthesized saponins whose genin is (a) 3b,12b,20-trihydroxydammar-24-ene (protopanaxadiol)/3b,6a,12b,20-
tetrahydroxydammar-24-ene (protopanaxatriol); (b) 3b,12b,25-trihydroxy-20,24-epoxydammarane/3b,6a,12b,25-tetrahydroxy-20,24-epoxydammarane; (c) 3b,12b-dihydrox-
ydammarane; K. Structures of ginseng saponin metabolites whose genin is 3b,12b,20-trihydroxydammar-24-ene (protopanaxadiol)/3b,6a,12b,20-tetrahydroxydammar-24-ene
(protopanaxatriol).
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Fig. 3. Probable pathways of the formation of artifactual saponins owing to heating. Deglycosylation and dehydration may occur at C-20 when a PPD- or PPT-type ginsenoside is
steamed or heat-processed. The resultant double bond is formed either between C-20 and C-21 or between C-20 and C-22, leading to positional and geometric isomerism. PPD,
protopanaxadiol; PPT, protopanaxatriol.
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Fig. 4. Suggested metabolic pathways of PPD- and PPT-type ginsenosides. PPD-type
ginsenosides tend to be deglycosylated at C-3, and M1 (compound K) may result.
PPT-type ginsenosides are deglycosylated at C-6 and/or C-20. PPD, protopanaxadiol;
PPT, protopanaxatriol.
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epoxydammar-3,12-dione. Fig. 2G-(b,c) show the structures of sa-
ponins with an epoxy group between C-12 and C-23 and between
C-20 and C-24, respectively.
2.6. Saponins isolated from P. ginseng with other aglycones
The genins of some saponins isolated from P. ginseng are
different from those aforementioned. Fig. 2H, I illustrate the
structures of ginsenosides with other backbones.
2.7. Synthetic saponins
Synthetic compounds whose structures are related to saponins
isolated from P. ginseng have been reported. In most cases, de-
rivatives of dammarane are synthesized from isolated ginsenosides
to enhance biological activity. Indeed, several acylated saponinshave been found to have antitumor activity [61,63]. In addition,
some derivatives of ocotillol have shown myocardial ischemia
protective effect [64]. Fig. 2J illustrates the structures of some
synthetic saponins.
2.8. Saponin metabolites
Most ginsenosides are metabolized by intestinal bacteria. Fig. 4
shows the suggested metabolic pathways of PPD- and PPT-type
ginsenosides. The former is deglycosylated at C-3 and trans-
formed to either M1 (compound K) or PPD. By contrast, the latter is
deglycosylated at C-6 and/or C-20, and eventually transformed to
PPT. Fig. 2K shows the structures of the saponin metabolites that
have not been reported as being present in raw or processed
ginseng.
3. Concluding remarks
Ginseng is well known for its beneﬁcial biological effects on the
human body. While the plant contains various ingredients, ginse-
nosides play a more signiﬁcant role in exerting pharmacological
actions than any other constituents. Of the great number of gin-
senosides present in P. ginseng, fewer than 10 account for most
ginsenoside contents. In particular, ginsenosides Rb1, Rb2, Rc, Rd,
Re, Rf, and Rg1 are most abundant in the roots of raw ginseng.
Intriguingly, chemical reactions during the processing of ginseng,
such as oxidation, hydrolysis, and/or dehydration, lead to the for-
mation of artifactual compounds, which often have enhanced
biological activities. Besides, orally administered ginsenosides un-
dergo biotransformations in the gastrointestinal tract, and some
metabolites produced by the action of bacteria have structures
different from those of naturally occurring ginsenosides. Here,
>100 ginsenosides have been classiﬁed according to their struc-
tural features.
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